The biotechnology research platform developer has closed a round co-led by Monsanto Growth Ventures that included Tencent and Baidu.

Neurodegenerative disease startup Prevail Therapeutics has raised series A funding from backers including Alexandria Venture Investments.

Humacyte, an Access Industries-backed developer of tissue-based biological repair technology, has now raised $290m in financing in total.

The pet food and health product maker has formed a corporate venturing fund called Companion Fund and an accelerator dubbed Leap.

Tanel Ozdemir, an alumnus of UCL, has joined Albion Capital as an analyst of the UCL Technology Fund.

Infosys-backed athlete analysis technology provider Whoop has added the NFL Players Association to its shareholders in its series C round.

Founding investors WuXi AppTec and Juno Therapeutics returned for a series A round that will support development of JW's cell-based therapy pipeline.

The diabetes treatment developer will target at least $400m from a Hong Kong offering that will allow WuXi PharmaTech to exit.

The company, led by two UW researchers, remains in stealth but is reportedly working on organism-resistant materials to ward against the threat of infection.